These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12156324)

  • 1. Contribution on the mode of action of oral ovulation inhibitors in humans. Report 2.
    Mall-haefeli M; Ludwig KS; Keller M; Weber W
    Z Geburtshilfe Gynakol; 1969 Aug; 171():1-12. PubMed ID: 12156324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian morphological changes with injectable contraceptives and their relation to cycle control.
    Yassin S; El-mahgoub S; Ammar R; Karim M
    Ain Shams Med J; 1971 Jul; 22(4):497-501. PubMed ID: 12256861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ultrasonic and hormonal monitoring of the ovaries during mini-dose oral contraception].
    Doyen J; Schaaps JP; Lambotte R
    Contracept Fertil Sex (Paris); 1987 May; 15(5):529-33. PubMed ID: 12268693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of different contraceptives upon the ovulation changes of the morphological study of the ovaries.
    Bedoya Havia M; Kesseur E; Garcia La Madrid M
    Ginecol Obstet (Lima); 1967 Dec; 13(3):177-92. PubMed ID: 12277382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Teratogenic and mutagenic risks of radiotherapy: when and how to prescribe contraception].
    Marty M; Mignot L; Gisselbrecht G; Morvan F; Gorins A; Boiron M
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):181-6. PubMed ID: 12280202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Triella: a French multicenter double blind clinical study].
    Castaigne JP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):445-53. PubMed ID: 12280213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical observations on LRH-A used for contraception by luteolysis in normal women--analysis of 88 cases].
    Lu RK; Chen HY; Liu Y; Zhang L; He YJ; Ge LJ; Yuan XW; Qui XD
    Shengzhi Yu Biyun; 1987; 7(1):39-40, 45-7. PubMed ID: 12341309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral contraception and its beneficial gynecological effects].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Mar; 16(3 Suppl):3-7. PubMed ID: 12282188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prospects for hormonal sterilization.
    Kurzrok R
    J Contracept; 1937 Feb; 2(2):27-9. PubMed ID: 12255369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amenorrhea following the administration of oral contraceptives].
    Gertrudis Diez MA
    Acta Ginecol (Madr); 1984 Apr; 41(4):201-6. PubMed ID: 12267262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of nor-ethisterone enanthate on the structure of ovary, particularly corpus luteum.
    Aghari K
    J Obstet Gynaecol India; 1970 Jun; 20(3):393-6. PubMed ID: 12275253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fertility and characteristics of ovulation after discontinuing oral contraception].
    Gaspard U; Lambotte R
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1005-10. PubMed ID: 12266509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral contraception: disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amenorrhea and the pill].
    Verdino P; Viard R; Harter M
    Lyon Mediterr Med Med Sud Est; 1983 Jan; 19(2):7067-74. PubMed ID: 12279701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of pelvic inflammatory disease in women using intra-uterine device--a prospective study at the Kenyatta National Hospital.
    Abdulla SH
    J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):156-8. PubMed ID: 12313676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal LHRH agonist (Buserelin) after ovulation: a post-coital contraceptive approach.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Contracept Deliv Syst; 1983 Apr; 4(2):107-25. PubMed ID: 12338631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern management of secondary amenorrhoea.
    Banerjee S
    Calcutta Med J; 1989; 86(5-6):46-9. PubMed ID: 12284231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility regulation technology: status and prospects.
    Segal SJ; Nordberg OS
    Popul Bull; 1977 Mar; 31(6):1-25. PubMed ID: 12335682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.